Status:
COMPLETED
Trial Assessing Renal Damage During Ureteroscopy
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Nephrolithiasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is an ongoing randomized controlled trial of patients undergoing URSLL with unilateral non-obstructing renal stones. Patients are randomized to undergo URSLL with either the TFL or Ho:YAG laser. ...
Detailed Description
Patients scheduled for ureteroscopic laser lithotripsy (URSLL) will be screened and if eligible and agreeable, enrolled into the study. Patients will then be randomized preoperatively via block random...
Eligibility Criteria
Inclusion
- Age greater than or equal to 18 years
- Patients undergoing unilateral ureteroscopic laser lithotripsy for the treatment of non-obstructing renal stones
- Total stone burden between 5 and 20 mm
Exclusion
- Presence of pre-existing indwelling ureteral stent
- Presence of hydronephrosis preoperatively (on either side)
- CKD as defined by eGFR \< 60 mL/min
- GU anatomical anomalies (including urinary diversion, solitary kidney, ureteral stricture disease, ureteropelvic junction obstruction)
Key Trial Info
Start Date :
October 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2022
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT05350423
Start Date
October 22 2021
End Date
November 28 2022
Last Update
December 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai West
New York, New York, United States, 10019